Skip to content
AnalystLens

PROCTER & GAMBLE Co 8-K Report (Jan 28, 1997)

Reports
Other Events
Filing Date
Filed January 28, 1997
Period End
January 28, 1997
Security
PG
In the record · 2016–202610-K1210-Q328-K226

PG filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 226 current reports (8-K) between 2016 and 2026.

  1. FY2019 annual report10-K · Aug ’19Aug ’19
  2. Leadership change8-K · Jan ’22Jan ’22
  3. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 8-K filed January 28, 1997. Cited figures are marked; the original filing is the authoritative source.

This Form 8-K, dated January 28, 1997, reports a small routine equity transaction.

On January 20 and 21, 1997, Procter & Gamble sold 6,154 shares of its common stock to employees of its subsidiaries for approximately $700,209,a or about $113.78 per share. The sale was made in reliance on Regulation S, which exempts offers and sales made outside the United States to non-U.S. persons, and no underwriter or placement agent was used. The filing is immaterial to investors.

The shares represent a negligible fraction of P&G's outstanding common stock, and the roughly $0.7 millionb in proceeds is trivial relative to the company's size. The implied price per share can serve as a reference point for the stock's trading level in late January 1997, though the filing does not state the pricing basis, such as market price or a plan-determined discount.

The filing is brief and does not disclose the specific employee plan, the pricing mechanism, or any change in share count beyond this transaction. Investors who want to assess dilution, employee compensation programs, or capital structure changes would need to consult P&G's annual report and proxy statement for those details.

Key Highlights

  1. P&G sold 6,154 common shares to subsidiary employees on January 20-21, 1997, for approximately $700,209.
  2. The implied price was roughly $113.78 per share.
  3. The sale was made under Regulation S, which covers offshore transactions with non-U.S. persons.
  4. No underwriter or placement agent was used, so the transaction was a direct sale to employees.
  5. The transaction is financially immaterial given P&G's size and share count.
  6. The filing is a routine Item 9 disclosure and does not signal a change in strategy, capital structure, or operations.
  7. The filing does not specify the employee plan or pricing basis, so details must come from other P&G disclosures.

Frequently Asked Questions

  1. Does this filing indicate any material change in P&G's financial position?

    No. The sale of 6,154 shares for about $700,000 is far too small to affect P&G's financial position, capital structure, or earnings. It is a routine employee share transaction.

  2. What does it mean that the shares were sold under Regulation S?

    Regulation S is an SEC safe harbor that allows securities to be offered and sold outside the United States to non-U.S. persons without SEC registration. Here, the sale to subsidiary employees was structured to fall under that exemption, which is common for employee offerings at foreign subsidiaries.

  3. Why did the company sell shares to its employees?

    The filing does not say. Companies typically sell shares to employees through stock purchase or compensation plans. The filing does not identify the specific plan, so the purpose must be confirmed from P&G's proxy statement or annual report.

  4. Does this sale dilute existing shareholders?

    Technically yes, since new shares were issued, but the dilution is negligible. Six thousand shares are a tiny fraction of P&G's total common shares outstanding.

  5. Should investors take any action based on this filing?

    No. The filing is informational and has no direct implications for valuation or investment decisions. Investors should focus on P&G's quarterly and annual results, strategic initiatives, and market position.